News

Filter

Current filters:

PfizerRapamune

1 to 9 of 17 results

Pfizer says Rapamune failed endpoints in renal transplant study

Pfizer says Rapamune failed endpoints in renal transplant study

09-11-2013

US pharma behemoth Pfizer released disappointing top-line results from a Phase IIIb/IV study of its already-marketed…

ImmunologicalsPfizerPharmaceuticalRapamuneResearch

Pfizer legacy company agrees near half billion dollar settlement with DoJ

31-07-2013

Wyeth Pharmaceuticals, a US pharma rival acquired by US behemoth Pfizer (NYSE:PFE) in 2009, has agreed…

FinancialImmunologicalsLegalMarkets & MarketingNorth AmericaPfizerPharmaceuticalRapamuneWyeth

Pfizer prevails in Rapamune patent dispute with Watson

01-02-2013

Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware…

ActavisGenericsImmunologicalsLegalNorth AmericaPatentsPfizerPharmaceuticalRapamuneWatson Pharmaceuticals

US lawmakers launch inquiry into allegations Wyeth/Pfizer marketed Rapamune to African Americans for not-FDA-approved uses

14-06-2010

The US House Oversight and Government Reform Committee, under the chairmanship of Representative Edolphus…

North AmericaOncologyPfizerPharmaceuticalPoliticsRapamuneRegulationWyeth

Everolimus trial halted after early PFS gains

10-03-2008

Swiss drug major Novartis says that a late-stage Phase III trial of its kidney cancer drug everolimus…

AspirinAvastinBayerBayerbevacizumabNexavarNovartisPfizerRapamuneRochesirolimusSorafenibSunitinib MalateSutentTemsirolimus InjectionToriselWyeth

1 to 9 of 17 results

Back to top